0
2021
Insulin Syringes Market

Insulin Syringes Market

by Syringe Size (3/10 cc Syringe (0.3ml), 1/ 2 cc Syringe (0.5ml), 1cc syringe (1ml), and Others), Disease (Type-1 Diabetes and Type-2 Diabetes), End User (Hospital & Clinics, Homecare Settings, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

Report Code: A03398
Pages: 201
Dec 2021 | 9720 Views
Author(s) : Sanjivan G, Vikita T , Onkar S
Tables: 116
Charts: 24
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Insulin Syringes Market

Request Now !

Global insulin syringes market was valued at $1,561.20 million in 2020, and is projected to reach $2,401.51 million by 2030, registering a CAGR of 4.4% from 2021 to 2030. Insulin regulates fat and carbohydrate metabolism in the body. It is a peptide hormone, which is secreted in the pancreas by beta cells of the islets of Langerhans and it helps to regulate the glucose metabolism. An insulin syringe aids in delivering insulin to diabetic patients in required doses. The insulin syringes consist of three parts-a needle, a barrel, and a plunger, and is available in various sizes. The needle is usually thin & short and covered with a special material such as silicone in order to allow it to slide through the skin causing minimal pain. Barrel is the chamber that holds the insulin. It is marked with calibrations designed to show the units of insulin being injected. The plunger is the narrow rod that slides up and down the length of the barrel. It serves to either draw the insulin into the barrel or release the insulin from the barrel through the needle. Furthermore, the size of the insulin syringe is selected based on the desired dosage of insulin to be administered to the diabetic patient.

The Insulin Syringes market is expected to be positively impacted by the COVID-19 pandemic. As patients with different health issues such as, diabetes and high blood pressure are at higher risk of getting affected by virus. It is found that the mortality rate is high in a patient with diabetes compared to the general population. The people having diabetes require continuous access to insulin (administrated with syringes or pens) and care.Thus, the adoption of insulin syringes and continuous glucose monitoring devices has increased for close monitoring and optimal management of diabetes.

The major factor that contributes to the growth of the insulin syringes market include surge in aging population and increased number of diabetic patients globally. Furthermore, other factors such as favorable government policies related to insulin syringes are the key factors that drive the growth of the market. In addition, surge in incidence of obesity and people adopting an unhealthy lifestyle supplement the growth of market. Moreover, rise in prevalence of various chronic diseases such as type-1 and type-2 diabetes, is another major factor that boosts the market growth. However, increased use of insulin pens and high costs of advanced insulin syringes are the factors that could hinder the growth of market. On the contrary, emerging markets are anticipated to offer significant growth opportunities for the market players in the future. 

Insulin-Syringes-Market

The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected more than 210 countries across the globe. Owing to the COVID-19 pandemic, governments across the globe announced country-wide lockdowns as well as social distancing measures to prevent collapse of the healthcare system. Governments also issued limitations and bans on medical procedures and elective surgeries. These restrictions continue to impact the growth of various industries and the immediate impact of the outbreak varies from industry to industry. The distribution, production, and supply chain have been affected, due to the implementation of lockdown across the globe

The overall impact of COVID-19 remains positive for insulin syringe market. Patients with different health issues such as, diabetes and high blood pressure are at higher risk of getting affected by this virus. It is found that the mortality rate is high in a patient with diabetes compared to the general population. The people having diabetes require continuous access to insulin (administered with syringes or pens) and care. Without or irregular supply of insulin devices due to pandemic can seriously affect the health of a person with diabetes especially who are diagnosed with type-1 diabetes as they are totally dependent on insulin.

According to National Center of Biotechnology Information, diabetes is treated with angiotensin converting enzymes inhibitors and this has been discovered that coronavirus binds to the target cells through this enzyme, an enzyme expressed in the blood vessels and lungs. As an increasing level of ACE2 enzyme found in diabetic patients, the chances of COVID-19 also increases in such patients.

As the diabetic patients are more prone to COVID-19 infection, they usually look for proper glycemic control. Thus, the adoption of insulin syringes and continuous glucose monitoring devices have made close monitoring and optimal management of diabetes possible. Furthermore, the companies are trying to supply essential healthcare insulin syringes, pumps, and others through different modes such as online portal, hospital pharmacies, and emergency medical stores. For instance, Ely Lilly had launched Diabetes Solution Center program to provide free insulin treatment option for financially affected patients who rely on insulin.  Thus, overall impact of COVID-19 remains positive for insulin syringes market.

Insulin Syriges Market Segmentation  

The insulin syringes market size is studied on the basis of syringe size, disease type end user, and region to provide a detailed assessment of the market. On the basis of syringe size, it is segmented into 3/10 cc Syringe (0.3ml), 1/ 2 cc Syringe (0.5ml), and 1cc syringe (1ml). On the basis of disease, it is bifurcated into type-1 diabetes and type-2 diabetes. By end user, it is fragmented into hospital, homecare setting, and nursing homes. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Syringe size segment review

By syringe size, the 3/10cc syringe (0.3ml) segment was the major revenue contributor, and is projected to grow significantly during the forecast period. The high prevalence of diabetes and obesity in developing countries, as well as significant use of 3/10 cc syringes by diabetic patients for administration of insulins in developing countries drive the growth of the global insulin syringes market.

Insulin Syringes Market
By Syringe Size

Your browser does not support the canvas element.

3/10 cc Syringes (0.3ml) segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Disease segment review

By disease, the type 2 diabetes segment was the major revenue contributor, and is projected to grow significantly, owing to increase in the prevalence of type-2 diabetes across the world. For instance, according to WHO, in 2019, about 462 million individuals are affected by type-2 diabetes, corresponding to 6.28% of the world’s population.

Insulin Syringes Market
By Disease

Your browser does not support the canvas element.

Type-2 Diabetes segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

End user segment review

By end user, the hospital & clinics segment was the major revenue contributor, and is projected to grow significantly during the forecast period, owing to increase in prevalence of chronic diseases such as diabetes and obesity among the population. In addition, rapid rise in geriatric population acts as a key driving force for the insulin syringes market. For instance, according to American Diabetes Association, in 2019, about 34.2 million people were diagnosed with diabetes, out of which 14.3 million people aged above 65 years were suffering from diabetes.

Insulin Syringes Market
By End User

Your browser does not support the canvas element.

Hospital & Clinics holds a dominant position in 2020 and continue to maintain lead in the forecast year

Get more information on this report : Request Sample Pages

Major key players that operate in insulin syringes market include Novo Nordisk A/S, Biocon Ltd, Abbott Laboratories, Terumo Corporation, Cardinal Health Inc, Beckton and Dickinson Company, Eli Lilly and Company, Nipro Medical Corporation, Medline Industries and Hindustan syringe and medical device Ltd.

Insulin Syringes Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

North America holds a dominant position in 2020 and continue to maintain lead in the forecast year

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the insulin syringes market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers insulin syringes analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook and global insulin syringes market growth.

Insulin Syringes Market Report Highlights

Aspects Details
By Syringe Size
  • 3/10 CC Syringe (0.3ml)
  • 1/2 CC Syringe (0.5ml)
  • 1CC Syringe (1ml)
  • Others
By Disease
  • Type 1 Diabetes
  • Type 2 Diabetes)
By End User
  • Hospitals & Clinics
  • Homecare Settings
  • Others)
By Region
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA
By Key Market Players
  • Novo Nordisk A/S
  • Biocon Ltd
  • Abbott Laboratories
  • Terumo Corporation
  • Cardinal Health Inc
  • Beckton and Dickinson Company
  • Eli Lilly and Company
  • Nipro Medical Corporation
  • Medline Industries
  • Hindustan syringe and medical device Ltd.
 

Loading Table Of Content...


 
 

Insulin regulates fat and carbohydrate metabolism in the body. It is a peptide hormone, which is secreted in the pancreas by beta cells of the islets of Langerhans and it helps to regulate the glucose metabolism. It causes skeletal muscle cells and fat tissues to absorb glucose from the blood. An insulin syringe aids in delivering insulin to diabetic patients in required doses. An insulin syringe aids in delivering insulin to diabetic patients in required doses. The insulin syringes consist of three parts-a needles, a barrel, and a plunger, and is available in various sizes.

Factors such increase adoption of insulin administration among the diabetic patients, surge in prevalence of type 1 and type 2 diabetes and increase in geriatric population across the world drives growth of the market. In addition, increasing incidence of obesity and people adopting an unhealthy lifestyle supplement the market growth. Furthermore, favorable government policies and technological advances such as innovation of prefilled insulin syringes have also fueled the growth of this market

In addition, North America is expected to offer remunerative growth opportunities to key players operating in the industry. This is majorly attributed to factors such as, increasing prevalence of diabetes, and new product launches by market players, are key opportunities driving the growth of the insulin syringes market

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The total market value of Insulin Syringes Market is $2,401.51 Million in 2030

A. The forecast period in the report is from 2021 to 2030

A. The market value of Insulin Syringes in 2020 was 1,561.20million in 2020

A. The base year for the report is 2020

A. Yes, Insulin Syringes Market companies are profiled in the report

A. The top companies that hold the market share in Insulin Syringes Market are Bekton Dickinson, Novartis AG, Nipro Corporation, Abbott Laboratories

A. No, there is no value chain analysis provided in the Insulin Syringes Market report

A. The key trends in the Insulin Syringes Market areincrease in prevalence of chronic diseasesuch as diabetes along with rise in elderly population are the key factors driving the market growth.t

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS

Purchase Full Report of
Insulin Syringes Market

Start reading instantly.
This Report and over 19,305+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Dec 2022 - Dec 2023)
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Dec 2022 - Dec 2023)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Dec 2022 - Dec 2023)
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Dec 2022 - Dec 2023)
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Dec 2022 - Dec 2023)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers